Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis

Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway

(2009) Soo-Jung Park et al.   BIOCHEMICAL PHARMACOLOGY

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy

(2009) Rhys D. Clyburn et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

TRAIL and cancer therapy

(2008) Frank A.E. Kruyt   CANCER LETTERS

Cellular FLICE-Like Inhibitory Protein (C-FLIP): A Novel Target for Cancer Therapy

(2008) Ahmad Safa et al.   CURRENT CANCER DRUG TARGETS

FLIP as an Anti-Cancer Therapeutic Target

(2008) Jin Kuk Yang   YONSEI MEDICAL JOURNAL